These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25958884)

  • 21. Declining responsiveness to influenza vaccination with progression of human pregnancy.
    Schlaudecker EP; Ambroggio L; McNeal MM; Finkelman FD; Way SS
    Vaccine; 2018 Jul; 36(31):4734-4741. PubMed ID: 29941326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.
    Christian LM; Beverly C; Mitchell AM; Karlsson E; Porter K; Schultz-Cherry S; Ramilo O
    Vaccine; 2017 Sep; 35(39):5283-5290. PubMed ID: 28778612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody dynamics of 2009 influenza A (H1N1) virus in infected patients and vaccinated people in China.
    Wang M; Yuan J; Li T; Liu Y; Wu J; Di B; Chen X; Xu X; Lu E; Li K; Liu Y; Wu Y; Chen X; He P; Wang Y; Liu J
    PLoS One; 2011 Feb; 6(2):e16809. PubMed ID: 21347418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
    Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
    Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine.
    Sun Y; Bian C; Xu K; Hu W; Wang T; Cui J; Wu H; Ling Z; Ji Y; Lin G; Tian L; Zhou Y; Li B; Hu G; Yu N; An W; Pan R; Zhou P; Leng Q; Huang Z; Ma X; Sun B
    PLoS One; 2010 Dec; 5(12):e14270. PubMed ID: 21151563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C.
    Ohfuji S; Fukushima W; Tamori A; Maeda K; Maeda A; Hirota Y
    Influenza Other Respir Viruses; 2013 May; 7(3):456-65. PubMed ID: 22897938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine.
    Zuccotti G; Pogliani L; Pariani E; Amendola A; Zanetti A
    JAMA; 2010 Dec; 304(21):2360-1. PubMed ID: 21119083
    [No Abstract]   [Full Text] [Related]  

  • 29. Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients.
    Cagigi A; Pensieroso S; Ruffin N; Sammicheli S; Thorstensson R; Pan-Hammarström Q; Hejdeman B; Nilsson A; Chiodi F
    Vaccine; 2013 Apr; 31(18):2231-7. PubMed ID: 23499520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.
    Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G
    Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.
    Azevedo LS; Gerhard J; Miraglia JL; Precioso AR; Tavares Timenetsky MD; Agena F; Gamba C; Shikanai Yasuda MA; David-Neto E; Pierrotti L
    Transpl Infect Dis; 2013 Dec; 15(6):612-8. PubMed ID: 24134688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic.
    Reed C; Katz JM; Hancock K; Balish A; Fry AM;
    PLoS One; 2012; 7(10):e48187. PubMed ID: 23118949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design.
    Ludvigsson JF; Ström P; Lundholm C; Cnattingius S; Ekbom A; Örtqvist Å; Feltelius N; Granath F; Stephansson O
    BMJ; 2015 Nov; 351():h5585. PubMed ID: 26572546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort study.
    Kang EK; Eun BW; Kim NH; Lim JS; Lee JA; Kim DH
    BMC Infect Dis; 2016 Aug; 16(1):438. PubMed ID: 27549626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.
    Salles MJ; Sens YA; Malafronte P; Souza JF; Vilas Boas LS; Machado CM
    Transpl Infect Dis; 2012 Dec; 14(6):564-74. PubMed ID: 22882692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination.
    Huijskens EG; Reimerink J; Mulder PG; van Beek J; Meijer A; de Bruin E; Friesema I; de Jong MD; Rimmelzwaan GF; Peeters MF; Rossen JW; Koopmans M
    PLoS One; 2013; 8(1):e54890. PubMed ID: 23365683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
    Strengell M; Ikonen N; Ziegler T; Kantele A; Anttila VJ; Julkunen I
    Influenza Other Respir Viruses; 2013 May; 7(3):431-8. PubMed ID: 22913369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in Taiwan.
    Lin SY; Wu ET; Lin CH; Shyu MK; Lee CN
    PLoS One; 2013; 8(6):e62983. PubMed ID: 23762229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.